Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Current Assets    
Cash and cash equivalents $ 1,842 $ 2,361
Restricted cash 25 173
Accounts receivable, net 6,121 5,824
Inventories, net 4,762 6,580
Prepaid expenses and other current assets 3,064 2,641
Total Current Assets 15,814 17,579
Noncurrent Assets    
Property and equipment, net 349 417
Right-of-use assets, operating lease 888 951
Intangible assets, net 14,259 14,641
Goodwill 18,614 18,614
Other assets 1,027 1,330
Total Assets 50,951 53,532
Current Liabilities    
Short term loan, net 17,023 16,061
Line of credit, net 5,366 4,819
Other liabilities 209 500
Accounts payable 4,226 4,049
Accrued liabilities 4,570 4,721
Deferred revenue 330 311
Operating lease liability, current portion 352 345
Warrant derivative liability 841 2,220
Total Current Liabilities 32,917 33,026
Noncurrent Liabilities    
Notes payable, net 17,559 16,370
Operating lease liability 566 641
Total Noncurrent Liabilities 18,125 17,011
Total Liabilities 51,042 50,037
Stockholders' Deficit    
Common stock, $0.001 par value, 88,000,000 shares authorized, 48,939,708 & 47,977,390 shares issued and outstanding at March 31, 2020 and December 31, 2019 49 48
Additional paid-in capital 200,051 194,150
Accumulated deficit (210,757) (201,269)
Total Stockholders' Deficit (10,657) (7,071)
Total Liabilities, Redeemable Preferred Stock and Stockholders' Deficit 50,951 53,532
Series E Preferred Stock [Member]    
Redeemable Series E Convertible Preferred Stock    
Redeemable Series E preferred stock, $0.001 par value, 2,900,000 shares authorized, 1,387,378 shares issued and outstanding at March 31, 2020 and December 31, 2019 $ 10,566 $ 10,566